Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
NCT06931548

Ways of Retaining the Inframammary Fold in Implant-based Breast Surgery

Led by Branch Office of "Hadassah Medical Ltd" · Updated on 2025-04-17

100

Participants Needed

1

Research Sites

204 weeks

Total Duration

On this page

Sponsors

B

Branch Office of "Hadassah Medical Ltd"

Lead Sponsor

F

Federal Research Clinical Center of Federal Medical & Biological Agency, Russia

Collaborating Sponsor

AI-Summary

What this Trial Is About

There is currently no consensus on the "gold standard" for Implant-based Breast reconstruction. In the United States, more than half of all breast reconstructions are performed using acellular dermal matrix (ADM). However, based on the findings of literature and systematic reviews, it can be cautiously said that synthetic meshes cause fewer complications with comparable aesthetic results and low cost. In our study, we propose using polytetrafluoroethylene (PTFE) mesh in implant-based breast reconstruction. This material has previously proven itself in cardiovascular, maxillofacial and neurosurgery, hernioplasty and as a suture material. Allogeneic dura mater, which has demonstrated comparable results in breast reconstruction with the literature, will be used as a comparison. The purpose of this study is to evaluate the efficacy and safety of a porous, non-biodegradable, synthetic polytetrafluoroethylene mesh for implant-based breast reconstruction in patients diagnosed with breast cancer. An allogeneic dura mater technique will be used as a control. Patients eligible for this study are classified according to the National Comprehensive Cancer Network (NCCN) guidelines as having stage 0-2 breast cancer. The primary questions this study aims to answer are: * What are the rates of major and minor complications associated with these techniques. Major complications will be defined as complications leading to reoperation. * How effective are PTFE mesh and dura in maintaining the inframammary fold and implant projection after breast reconstruction? * What is the patient satisfaction rate with the surgical results? Patients will be randomly assigned to the study but will know which technique will be used in their particular case. Patients included in this study will undergo subcutaneous mastectomy or skin-sparing mastectomy using standard techniques with simultaneous implantation using PTFE mesh or allogeneic dura mater graft. In our opinion, the mesh and graft will stabilize the projections of the inframammary fold and breast implant. After the surgery, all minor and major complications will be recorded for 6 months. For this, both physical examination and radiological diagnostic methods will be used, including breast ultrasound and MRI with contrast. Revision surgeries will be performed if necessary. Projections of the inframammary fold and breast implant will also be measured in order to determine the effectiveness of the compared techniques. Patients will be asked to complete the BREAST-Q Version 2.0© Reconstruction Module questionnaire to determine satisfaction with the surgical outcome. The results of the study will help the professional community to determine the most effective method of Implant-based Breast reconstruction and will be published in peer-reviewed scientific journals.

CONDITIONS

Official Title

Ways of Retaining the Inframammary Fold in Implant-based Breast Surgery

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • White women
  • Breast cancer stage 0-II
  • Indications for breast reconstruction
  • Consent to participate in the study and photographic documentation
Not Eligible

You will not qualify if you...

  • Non-white women
  • Breast cancer stage III-IV
  • Tubular breast
  • Mental and cognitive health disorders
  • Failure to comply with postoperative recommendations such as premature physical activity, not wearing compression underwear, missing scheduled visits, or refusing photo documentation
  • Patient refusal to participate in the study at any stage

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

The Branch of Hadassah Medical LTD

Moscow, Skolkovo Innovation Center, Russia, 121205

Actively Recruiting

Loading map...

Research Team

A

Artem Mishin, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here